# A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer.

> **NCT04738019** · — · COMPLETED · sponsor: **LG Chem** · enrollment: 1022 (actual)

## Conditions studied

- Healthy Condition

## Interventions

- **DIAGNOSTIC_TEST:** Medical examination or treatment.

## Key facts

- **NCT ID:** NCT04738019
- **Lead sponsor:** LG Chem
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-18
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-02-28
- **Target enrollment:** 1022 (ACTUAL)
- **Last updated:** 2023-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04738019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04738019, "A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04738019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*